Skip to main content
AAN.com
Article
September 25, 2020
Open Access

Paraneoplastic anti-NMDA receptor encephalitis in 1830?

Abstract

Objective

Our aim was to identify patients with probable anti-NMDA receptor encephalitis among historical medical cases.

Method

A case report published in leading Hungarian-, German- and Italian-language medical journals in the early 1840s was revisited.

Results

In 1830, an 18-year-old, healthy woman suffered epileptic seizures, followed by a 6-day-long state characterized by catalepsy, unresponsiveness, motionless, and light breathing. Her symptoms regularly returned in the following 1.5 years. Meanwhile, a progressively growing huge abdominal tumor appeared. One day, she suddenly started vomiting a large amount of foul-smelling pus mixed with blood, accompanied by bone fragments. Pus mixed blood with some membranous substance was also evacuated through the anus and vagina. After this event, she completely recovered; 1.5 years later, she married and later gave birth to 3 healthy children. The patient remained healthy during the 11-year follow-up.

Conclusions

We suggest that in the description of a paraneoplastic case, an anti-NMDA receptor encephalitis can be dated back as far as to the 19th century, with an especially rare type of resolution: the disappearance of the symptoms after the spontaneous elimination of an ovarian teratoma.
Anti-NMDA receptor encephalitis was discovered by Dalmau et al.1,2 in 2005/2007, although cases were probably described already in 1997.3,4 Moreover, because of revisiting published cases dating back as far as the 19th century, more and more cases are suggested to be of anti-NMDA receptor encephalitis etiology. Merwick et al.5 pointed out that from the case series published by Bickerstaff—in which Bickerstaff encephalitis was described—in one patient, the symptoms were indicative of anti-NMDA receptor encephalitis. In the late 1800s, ovariotomy (Battey's operation) was introduced as a treatment of—among others—“histeroepilepsy.”6 In the course of the recent revisitation of these published cases, symptoms can also be attributed to anti-NMDA receptor encephalitis in more than one patient; this suggestion is also supported by the observation of Battey, namely that “cystic degeneration” was common in the resected ovaries.6 This is the most common autoimmune encephalitis, where 80% of patients are women with a median age of 21.7 Epileptic seizures occur in 76%,8 catatonia-like episodes in 70%,9 whereas hypoventilation in 66% of patients.8 In adult women patients, anti-NMDA receptor encephalitis is associated with ovarian teratoma in 58% of cases.7 Other tumors are rare: in paraneoplastic cases, 94% of the underlying tumor is ovarian teratoma.7
We found an interesting case report published in leading Hungarian-, German- and Italian-language medical journals referring to a presentation at the 3rd Meeting of the Italian Scientists in Florence held in 1841.1012 We suggest that the description of an anti-NMDA receptor encephalitis can be dated back as far as to the 19th century.

Case

On September 17, 1841, the case was presented by Dr. Odoardo Linoli (figure).1012 In 1830, an 18-year-old, hitherto healthy female patient suffered epileptic seizures, followed by a strange 6-day-long state characterized by a “catalepsy” pose and an unresponsive motionless state. The only sign of life was a very light breathing. Epileptic seizures and the catalepsy regularly returned in the following 1.5 years. Meanwhile, a progressively growing huge abdominal tumor appeared, which reached the level of the chest on the left side. One day, she suddenly started vomiting a large amount of coffee-colored liquid. Two weeks later, she vomited a foul-smelling pus mixed with blood. This was accompanied by more than 100 bone fragments. Some of these fragments were flat, others were long- or ball-shaped. Pus-mixed blood with some membranous substance was also evacuated through the anus and vagina. After this event, both epileptic seizures and “catalepsy” states disappeared, and she apparently became healthy again; 1.5 years later, she married and later gave birth to 3 healthy children. At the time of Dr. Linoli's presentation (11 years after the disease onset), she was in excellent health. During the discussion, Dr. Linoli argued that the abdominal tumor was probably a “fetal cyst” or “fetus in fetu.” Prof. Carlo Burci—the chairman of the section—suggested that the tumor could have been a “skin cyst,” whereas others speculated that it could have been an extrauterine pregnancy.
Figure Case presentation
The title page of the Österreichische Medizinische Wochenschrift from 1843 (A) and the case presentation in German (B). Available at the Bayerische Staatsbibliothek München, H.misc. 33 t-16, S. 244, urn:nbn:de:bvb:12-bsb10737557-2.

Discussion

The medical language in the first half of the 19th century was certainly different from today. The reliability of the description is enhanced by the fact that the case has been described in 3 different languages in the 1840s.1012 The case was presented by Odoardo Linoli (1801–1886), a well-known surgeon from Pietrasanta,13 and discussed by Carlo Burci,14 who was the professor of surgery at the University of Pisa, indicating that the case was observed and discussed by the most prestigious professionals of that time.
We tried to interpret this case report according to today's medical concepts. Although catatonia was not described as such until 1874, the described motionless and unresponsive state accompanied by catalepsy meet the criteria of a catatonia.15 Another issue is the type of the described huge abdominal tumor that contained bone fragments.
According to Dr. Linoli's interpretation, it was a “fetus in fetu.” Fetus in fetu is extremely rare in adulthood16 and should contain vertebral axis or limbs, otherwise it should classify as teratoma.17 Dr. Burci suggested that the tumor was a “skin cyst.” According to today's nomenclature, dermoid cyst (i.e., skin-like cyst) is a synonym for teratoma. The presence of bone is not unusual in teratoma.18 Based on the presence of bone, a teratoma was diagnosed during a paleopathological examination of a female skeleton from the late Roman age.19
Ovarian teratomas without treatment can reach a huge size, some of them can be up to 30 cm in diameter.18 Not only the size, localization, and the presence of bone but also the strange elimination of the tumor through the gastrointestinal system and vagina may also support the concept of teratoma. Teratomas (dermoid cysts) can perforate into the adjacent organs including bowel and vagina.2023 For example, Flood et al.22 reported a 23-year-old woman who discovered teeth-like structures in her underwear, which were the contents of an ovarian teratoma excreted in the vagina through a fistula. Mitui et al.23 reported a 72-year-old woman whose diarrhea, in which she found hair, was caused by an ovarian teratoma perforating into the bowels.
Summarizing our interpretation, a young woman had newly onset seizures, followed by catatonia-like symptoms and hypoventilation. This was associated with an abdominal tumor, which was probably a teratoma. The symptoms disappeared after the spontaneous elimination of the tumor, and the patient remained healthy during the 11-year follow-up.
According to a recent position study, new-onset seizures and altered mental status (unresponsive state) with subacute onset meet the criteria for “possible autoimmune encephalitis.”24 Epileptic seizures, altered mental status, abnormal posturing, and hypoventilation meet the symptoms criteria for “possible anti-NMDA receptor encephalitis.”24 The young age and female sex as well as the presence of ovarian teratoma also strengthen our assumption that Dr. Linoli's case study might be the first description of anti-NMDA receptor encephalitis.
In paraneoplastic anti-NMDA receptor encephalitis, the symptoms usually resolve after tumor removal, may that be either ovarian or extraovarian.7,25 Regarding Dr. Linoli's patient, the symptoms were present when the tumor was present and disappeared after the tumor also disappeared. Thus, we state that the description of a paraneoplastic story can be dated back as far as to 1830, ahead of the description of Trousseau's syndrome in 1865.26

Appendix Authors

References

1.
Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25–36.
2.
Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 2005;58:594–604.
3.
Nokura K, Yamamoto H, Okawara Y, Koga H, Osawa H, Sakai K. Reversible limbic encephalitis caused by ovarian teratoma. Acta Neurol Scand 1997;95:367–373.
4.
Okamura H, Oomori N, Uchitomi Y. An acutely confused 15-year-old girl. Lancet 1997;350:488.
5.
Merwick A, Dalmau J, Delanty N. Insights into antibody-associated encephalitis—Bickerstaff's 1950's papers revisited. J Neurol Sci 2013;334:167–168.
6.
Komagamine T, Kokubun N, Hirata K. Battey's operation as a treatment for hysteria: a review of a series of cases in the nineteenth century. Hist Psychiatry 2020;31:55–66.
7.
Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013;12:157–165.
8.
Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091–1098.
9.
Espinola-Nadurille M, Flores-Rivera J, Rivas-Alonso V, et al. Catatonia in patients with anti-NMDA receptor encephalitis. Psychiatry Clin Neurosci 2019;73:574–580.
10.
Linoli O. Fall von Epilepsie mint Katalepsie [A case of epilepsy with catalepsy, German]. Österreichische Medizinische Wochenschrift 1843;12:319. Available at (free access): opacplus.bsb-muenchen.de/Vta2/bsb10086743/bsb:5976959?page=325. Accessed June 23, 2020.
11.
Third Meeting of Italian Scientists in Florence. Annali Universali di Medicina 1842;40:17–20. Available at (free access): archive.org/details/s12id13209690/page/17. Accessed June 23, 2020.
12.
Bugát P, Flór F. Kivonatok idegen lapokbul és munkákbul. Kór- és gyógytudomány. Nehézkor dermengéssel. [Extracts from foreign works. Pathology and medicine. Epilepsy with catalepsy, Hungarian] Orvosi Tár 1843;17:295. Available at (free access): library.hungaricana.hu/hu/view/ORSZ_ORVO_OT_1843_04/. Accessed June 23, 2020.
13.
Wikipedia article. Available at: treccani.it/enciclopedia/odoardo-linoli_(Dizionario-Biografico)/. Accessed June 12, 2020.
14.
Wikipedia article. Available at: it.wikipedia.org/wiki/Carlo_Burci. Accessed June 12, 2020.
15.
Tandon R, Heckers S, Bustillo J, et al. Catatonia in DSM-5. Schizophr Res 2013;150:26–30.
16.
Kumar A, Paswan SS, Kumar B, Kumar P. Fetus in fetu in an adult woman. BMJ Case Rep 2019;12:e230835.
17.
Willis RA. The structure of teratoma. J Pathol Bacteriol 1935;40:1–36.
18.
Caruso PA, Marsh MR, Minkowitz S, Karten G. An intense clinicopathologic study of 305 teratomas of the ovary. Cancer 1971;27:343–348.
19.
Armentano N, Subirana M, Isidro A, Escala O, Malgosa A. An ovarian teratoma of late Roman age. Int J Paleopathol 2012;2:236–239.
20.
von-Walter AR, Nelken RS. Benign cystic ovarian teratoma with a fistula into the small and large bowel. Obstet Gynecol 2012;119:434–436.
21.
Zarain García F. Teratoma quístico del ovario con absceso y fístula a vagina (Cystic teratoma of the ovary with abscess and fistula in the vagina [in Spanish]). Ginecol Obstet Mex 1974;36:49–53.
22.
Flood K, Breathnach F, Gleeson N. An unusual presentation of a dermoid cyst. J Obstet Gynaecol 2010;30:72–73.
23.
Mitui AH, Fujita R, Sugata F, Kienebuchi M, Suzuki K, Sagawa F. A case of ovarian dermoid cyst with malignant transformation perforated into the rectosigmoid colon and small intestine. Endoscopy 1983;15:331–333.
24.
Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016;15:391–404.
25.
Kümpfel T, Gerdes LA, Heck C, Prüss H. Delayed diagnosis of extraovarian teratoma in relapsing anti-NMDA receptor encephalitis. Neurol Neuroimmunol Neuroinflamm 2016;3:e250. doi: 10.1212/NXI.0000000000000250.
26.
Darnell RB, Posner JB. Paraneoplastic Syndromes. Oxford/New York: Oxford University Press; 2011.

Information & Authors

Information

Published In

Neurology® Neuroimmunology & Neuroinflammation
Volume 7Number 6November 2020
PubMed: 32978290

Publication History

Received: July 30, 2020
Accepted: August 12, 2020
Published online: September 25, 2020
Published in print: November 2020

Permissions

Request permissions for this article.

Disclosure

None of the authors report anything to disclose. Go to Neurology.org/NN for full disclosures.

Study Funding

Study funded by the Hungarian Brain Research Program (2017-1.2.1-NKP-2017-00002), NKFIH EFOP-3.6.2-16-2017-00008 government-based funds. Our research was partly financed by the Higher Education Institutional Excellence Program of the Ministry of Human Capacities in Hungary, within the framework of the 5th thematic program of the University of Pécs, Hungary (20765/3/2018/FEKUSTRAT). The study was furthermore supported by the University of Pécs Medical School.

Authors

Affiliations & Disclosures

Dalma Tényi, MD, PhD
From the Department of Neurology (D.T., N.K., J.J.), University of Pécs, Medical School, Hungary; National Institute of Clinical Neuroscience (A.S.), Budapest, Hungary; MTA-PTE Clinical Neuroscience MRI Research Group (N.K., J.J.), Hungary; Department of Neurology (Z.I.), Odense University Hospital, Denmark; and Department of Clinical Research (Z.I.), University of Southern Denmark, Odense.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Anna Szűcs, MD, PhD
From the Department of Neurology (D.T., N.K., J.J.), University of Pécs, Medical School, Hungary; National Institute of Clinical Neuroscience (A.S.), Budapest, Hungary; MTA-PTE Clinical Neuroscience MRI Research Group (N.K., J.J.), Hungary; Department of Neurology (Z.I.), Odense University Hospital, Denmark; and Department of Clinical Research (Z.I.), University of Southern Denmark, Odense.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Norbert Kovács, MD, PhD, DSc
From the Department of Neurology (D.T., N.K., J.J.), University of Pécs, Medical School, Hungary; National Institute of Clinical Neuroscience (A.S.), Budapest, Hungary; MTA-PTE Clinical Neuroscience MRI Research Group (N.K., J.J.), Hungary; Department of Neurology (Z.I.), Odense University Hospital, Denmark; and Department of Clinical Research (Z.I.), University of Southern Denmark, Odense.
Disclosure
Scientific Advisory Boards:
1.
Abbvie, Abbott, Medtronic, TEVA
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Hungarian subsidiaries of Medtronic. Boehringer Ingelheim. Novartis. GlaxoSmithKline. UCB, Krka and Abbvie
Editorial Boards:
1.
Ideggyóygászati Szemle, behavioural neurology
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
This study was supported by the Hungarian Brain Research Program (2017-1.2.1-NKP-2017-00002), NKFIH EFOP-3.6.2-16-2017-00008, NKFIH SNN125143, and ÚNKP-17- 4 -I.- PTE-311 government-based funds. Our research was partly financed by the Higher Education Institutional Excellence Program of the Ministry of Human Capacities in Hungary, within the framework of the 5th thematic program of the University of Pécs, Hungary (20765/3/2018/FEKUSTRAT
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Zsolt Illés, MD, PhD, DSc
From the Department of Neurology (D.T., N.K., J.J.), University of Pécs, Medical School, Hungary; National Institute of Clinical Neuroscience (A.S.), Budapest, Hungary; MTA-PTE Clinical Neuroscience MRI Research Group (N.K., J.J.), Hungary; Department of Neurology (Z.I.), Odense University Hospital, Denmark; and Department of Clinical Research (Z.I.), University of Southern Denmark, Odense.
Disclosure
Scientific Advisory Boards:
1.
(1) Biogen(2) Novartis(3) Sanofi-Aventis-Genzyme(4) Teva Pharmaceuticals(5) Roche
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1) Biogen Idec(2) Novartis(3) Sanofi-Aventis-Genzyme(4) Teva Pharmaceuticals(5) Bayer Healthcare(6) Merck Serono(7) Roche
Editorial Boards:
1.
(1) Clinical and Experimental Neuroimmunology(2) Frontiers in Neurology(3) Frontiers in Immunology
Patents:
1.
Lambertsen K, Clausen B, Nielsen HH, Finsen B, Illes Z. 2015. Fumaric acid derivates for Medical use. No. PCT/DK2015/050344. The use of fumaric acid derivates in acute ischemic stroke.
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
(1) Biogen(2) Merck(2) Sanofi-Genzyme
Research Support, Government Entities:
1.
Region of Southern Denmark, primary investigator, 2014Odense University Hospital, primary investigator, 2016
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
(1) Scleroseforeningen(2) Lundbeckfonden(3) Direktor Ejnar Jonasson, kaldet Johnsen, og Hustru's Mindelegat(4) Jascha Fonden
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
József Janszky, MD, PhD, DSc
From the Department of Neurology (D.T., N.K., J.J.), University of Pécs, Medical School, Hungary; National Institute of Clinical Neuroscience (A.S.), Budapest, Hungary; MTA-PTE Clinical Neuroscience MRI Research Group (N.K., J.J.), Hungary; Department of Neurology (Z.I.), Odense University Hospital, Denmark; and Department of Clinical Research (Z.I.), University of Southern Denmark, Odense.
Disclosure
Scientific Advisory Boards:
1.
(1) UCB Hungary (Commercial)
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1) UCB Hungary speaker honoraria (2) Richter Gedeon Ltd speaker honoraria(3) GL Pharma (Gerot)speaker honoraria, travel
Editorial Boards:
1.
Editorial board member:(1) Ideggyogyaszati Szemle since 2006- (2) Behavioural Neurology since 2017- (3) Diagnostics since 2020-
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
Ministry of Innovation and Technology, Hungary: Hungarian Brain Research Program (2017-1.2.1-NKP-2017-00002), Ministry of Innovation and Technology, Hungary: NKFIH EFOP-3.6.2-16-2017-00008 government-based funds. Ministry of Innovation and Technology, Hungary: Higher Education Institutional Excellence Program of the Ministry of Human Capacities in Hungary, within the framework of the 5th thematic program ("neurology") of the University of Pécs, Hungary (20765/3/2018/FEKUSTRAT)
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE

Notes

Correspondence Dr. Janszky [email protected]
Go to Neurology.org/NN for full disclosures. Funding information is provided at the end of the article.
The Article Processing Charge was funded by University of Pécs.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Encephalitis lethargica: clinical features and aetiology, Brain Communications, 6, 5, (2024).https://doi.org/10.1093/braincomms/fcae347
    Crossref
  2. Bilateral hearing loss caused by anti‐NMDA receptor encephalitis with teratoma: A case report, Ibrain, (2023).https://doi.org/10.1002/ibra.12116
    Crossref
  3. Anti-NMDAR Encephalitis, Autoimmune Encephalitis and Related Disorders of the Nervous System, (210-254), (2022).https://doi.org/10.1017/9781108696722.009
    Crossref
  4. Research progress in teratoma‐associated anti‐N‐methyl‐D ‐aspartate receptor encephalitis: The gynecological perspective , Journal of Obstetrics and Gynaecology Research, 47, 11, (3749-3757), (2021).https://doi.org/10.1111/jog.14984
    Crossref
  5. N2 year in review, Neurology Neuroimmunology & Neuroinflammation, 8, 1, (2020)./doi/10.1212/NXI.0000000000000925
    Abstract
  6. A probable case of anti-NMDAR encephalitis from 1830, Neurology Neuroimmunology & Neuroinflammation, 7, 6, (2020)./doi/10.1212/NXI.0000000000000901
    Abstract
Loading...

View Options

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text
Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

Figures

Tables

Media

Share

Share

Share article link

Share